• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biogen Idec Inc

+ Add to Watchlist

BIIB:US

303.550 USD 4.450 1.49%

As of 20:10:00 ET on 11/21/2014.

Snapshot for Biogen Idec Inc (BIIB)

Open: 305.280 Day's Range: 301.320 - 305.280 Volume: 1,828,008
Previous Close: 299.100 52wk Range: 270.270 - 358.890 1-Yr Rtn: +6.28%

Stock Chart for BIIB

No chart data available.
  • BIIB:US 303.550
  • 1D
  • 1M
  • 1Y
299.100
Interactive BIIB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIIB

Current P/E Ratio (ttm) 29.3542
Estimated P/E(12/2014) 22.4320
Relative P/E vs. SPX 1.6048
Earnings Per Share (USD) (ttm) 10.3409
Est. EPS (USD) (12/2014) 13.5320
Est. PEG Ratio 1.0655
Market Cap (M USD) 71,684.97
Shares Outstanding (M) 236.16
30 Day Average Volume 1,708,103
Price/Book (mrq) 6.8745
Price/Sale (ttm) 7.9509
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIIB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BIIB

Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

George A ScangosChief Executive OfficerSusan H AlexanderExec VP/Chief Legal Ofcr/Secy
Paul J ClancyExec VP:Finance/CFOAdriana Karaboutis "Andi"Exec VP:Tech & Bus Solutions
More Company Profile & Key Executives for BIIB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil